NO20030795D0 - Kinazolinderivater - Google Patents

Kinazolinderivater

Info

Publication number: NO20030795D0
Authority: NO; Norway
Prior art keywords: quinazoline
Prior art date: 2000-08-21

Application number

NO20030795A

Other languages

English (en)

Other versions

NO20030795L (no

NO326515B1 (no

Inventor

Laurent Francois And Hennequin

Patrick Ple

Christine Marie Paul Lambert

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-21

Filing date

2003-02-20

Publication date

2003-02-20

2003-02-20 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-02-20 Publication of NO20030795D0 publication Critical patent/NO20030795D0/no

2003-04-04 Publication of NO20030795L publication Critical patent/NO20030795L/no

2008-12-22 Publication of NO326515B1 publication Critical patent/NO326515B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Obesity (AREA)
Oncology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20030795A 2000-08-21 2003-02-20 Kinazolinderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat NO326515B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP00402320		2000-08-21
EP01401006		2001-04-19
PCT/GB2001/003649 WO2002016352A1 (en)	2000-08-21	2001-08-15	Quinazoline derivatives

Publications (3)

Publication Number	Publication Date
NO20030795D0 true NO20030795D0 (no)	2003-02-20
NO20030795L NO20030795L (no)	2003-04-04
NO326515B1 NO326515B1 (no)	2008-12-22

Family

ID=26073540

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030795A NO326515B1 (no)	2000-08-21	2003-02-20	Kinazolinderivater, anvendelse og fremstilling derav, samt farmasoytisk preparat

Country Status (21)

Country	Link
US (1)	US7115615B2 (no)
EP (1)	EP1313727A1 (no)
JP (1)	JP2004506732A (no)
KR (2)	KR100821446B1 (no)
CN (1)	CN100347169C (no)
AR (1)	AR033560A1 (no)
AU (2)	AU2001278609B2 (no)
BR (1)	BR0113358A (no)
CA (1)	CA2419301C (no)
CZ (1)	CZ2003486A3 (no)
EE (1)	EE05387B1 (no)
IL (2)	IL154131A0 (no)
MX (1)	MXPA03001332A (no)
MY (1)	MY129809A (no)
NO (1)	NO326515B1 (no)
NZ (1)	NZ523702A (no)
PL (1)	PL202812B1 (no)
RU (1)	RU2267489C2 (no)
SK (1)	SK2142003A3 (no)
TW (1)	TWI280960B (no)
WO (1)	WO2002016352A1 (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA73993C2 (uk)	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
AU2001292138A1 (en)	2000-10-13	2002-04-22	Astrazeneca Ab	Quinazoline derivatives with anti-tumour activity
AU2001292137A1 (en)	2000-10-13	2002-04-22	Astrazeneca Ab	Quinazoline derivatives
JP4564713B2 (ja)	2000-11-01	2010-10-20	ミレニアム・ファーマシューティカルズ・インコーポレイテッド	窒素性複素環式化合物、ならびに窒素性複素環式化合物およびその中間体を作製するための方法
WO2002085895A1 (en) *	2001-04-19	2002-10-31	Astrazeneca Ab	Quinazoline derivatives
ES2272737T3 (es)	2001-07-16	2007-05-01	Astrazeneca Ab	Derivados de quinolina y su uso como inhibidores de tirosina quinasas.
GB0128109D0 (en)	2001-11-23	2002-01-16	Astrazeneca Ab	Therapeutic use
AU2002365664A1 (en) *	2001-12-05	2003-06-17	Astrazeneca Ab	Quinoline derivatives as antitumour agents
US7268230B2 (en) *	2002-02-01	2007-09-11	Astrazeneca Ab	Quinazoline compounds
TWI324597B (en) *	2002-03-28	2010-05-11	Astrazeneca Ab	Quinazoline derivatives
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
GB0215823D0 (en)	2002-07-09	2002-08-14	Astrazeneca Ab	Quinazoline derivatives
JP2005536486A (ja) *	2002-07-09	2005-12-02	アストラゼネカアクチボラグ	癌の処置に使用するためのキナゾリン誘導体
EP1521747B1 (en)	2002-07-15	2018-09-05	Symphony Evolution, Inc.	Receptor-type kinase modulators and methods of use
GB0225579D0 (en) *	2002-11-02	2002-12-11	Astrazeneca Ab	Chemical compounds
CN100354278C (zh) *	2002-11-04	2007-12-12	阿斯利康(瑞典)有限公司	作为src酪氨酸激酶抑制剂的喹唑啉衍生物
ES2300619T3 (es)	2002-11-04	2008-06-16	Astrazeneca Ab	Derivados de quinolina como inhibidores de src tirosina quinasa.
US7109337B2 (en)	2002-12-20	2006-09-19	Pfizer Inc	Pyrimidine derivatives for the treatment of abnormal cell growth
AU2003285614B2 (en)	2002-12-20	2009-05-14	Pfizer Products, Inc.	Pyrimidine derivatives for the treatment of abnormal cell growth
GB0307333D0 (en) *	2003-03-29	2003-05-07	Astrazeneca Ab	Therapeutic agent
GB0310401D0 (en) *	2003-05-07	2003-06-11	Astrazeneca Ab	Therapeutic agent
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
MXPA06002964A (es)	2003-09-16	2006-06-14	Astrazeneca Ab	Derivados de quinazolina como inhibidores de cinasa de tirosina.
ES2925655T3 (es)	2003-09-26	2022-10-19	Exelixis Inc	Moduladores c-Met y métodos de uso
EP1713781B1 (en)	2004-02-03	2008-11-05	AstraZeneca AB	Quinazoline derivatives
JP2007537230A (ja)	2004-05-14	2007-12-20	ファイザー・プロダクツ・インク	異常細胞増殖の処置用のピリミジン誘導体
WO2005111024A1 (en)	2004-05-14	2005-11-24	Pfizer Products Inc.	Pyrimidine derivatives for the treatment of abnormal cell growth
JP2007537238A (ja)	2004-05-14	2007-12-20	ファイザー・プロダクツ・インク	異常細胞増殖の治療のためのピリミジン誘導体
RU2007114080A (ru) *	2004-10-13	2008-11-27	Вайет (Us)	N-бензилсульфонил-замещенные аналоги анилинопиримидина
GB0427697D0 (en) *	2004-12-17	2005-01-19	Astrazeneca Ab	Chemical process
WO2007020964A1 (ja) *	2005-08-17	2007-02-22	Ube Industries, Ltd.	４－ハロカテコール化合物の製法
CA2654583C (en) *	2006-07-13	2015-11-24	Janssen Pharmaceutica N.V.	Mtki quinazoline derivatives
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
CA2672893C (en)	2006-12-15	2016-02-23	Abraxis Bioscience, Inc.	Triazine derivatives and their therapeutical applications
EP2118075A1 (de)	2007-02-06	2009-11-18	Boehringer Ingelheim International GmbH	Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
TWI377944B (en) *	2007-06-05	2012-12-01	Hanmi Holdings Co Ltd	Novel amide derivative for inhibiting the growth of cancer cells
CN101939316B (zh)	2008-02-07	2013-10-02	贝林格尔.英格海姆国际有限公司	螺环杂环化合物、含有所述化合物的药物、其用途及其制备方法
BRPI0912170A2 (pt)	2008-05-13	2015-10-13	Astrazeneca Ab	composto, forma a, processo para a preparação da mesma, composição farmacêutica, uso de um composto, e, método para tratar um câncer em um animal de sangue quente
US8648191B2 (en)	2008-08-08	2014-02-11	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
WO2010030835A2 (en) *	2008-09-11	2010-03-18	Wyeth Llc	Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
RU2527269C2 (ru) *	2008-09-29	2014-08-27	Cертрис Фармасьютикалз, Инк.	Аналоги хроменона в качестве модуляторов сиртуина
KR20250123237A (ko)	2009-01-16	2025-08-14	엑셀리시스, 인코포레이티드	암의 치료를 위한 ｎ-（４-｛〔６，７-비스（메틸옥시）퀴놀린-4-일〕옥시｝페닐）-ｎ＇-（４-플루오로페닐）사이클로프로판-1,1-디카르복사미드의 말산염 및 그 결정형
WO2010144550A1 (en)	2009-06-09	2010-12-16	Abraxis Bioscience, Llc	Triazine derivatives and their therapeutical applications
BRPI1011319A2 (pt)	2009-06-09	2016-06-21	California Capital Equity Llc	derivados de triazina benzil-substituídos e suas aplicações terapêuticas
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
CN102617463A (zh) *	2012-02-28	2012-08-01	苏州卡耐博生物技术有限公司	喹啉衍生物和喹唑啉衍生物及它们的制备方法
CN108064274A (zh)	2014-07-30	2018-05-22	耶达研究及发展有限公司	用于培养多能干细胞的培养基
AU2019255310B2 (en)	2018-04-18	2022-11-24	Constellation Pharmaceuticals, Inc.	Modulators of methyl modifying enzymes, compositions and uses thereof
EP3797108B1 (en)	2018-05-21	2022-07-20	Constellation Pharmaceuticals, Inc.	Modulators of methyl modifying enzymes, compositions and uses thereof
EP3914698B1 (en)	2019-01-23	2024-12-11	Yeda Research and Development Co. Ltd	Culture media for pluripotent stem cells
EP4003532B1 (en)	2019-07-24	2024-09-04	Constellation Pharmaceuticals, Inc.	Crystalline forms of 7-chloro-2-(4-(3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-n-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide
CN116120273B (zh) *	2023-02-15	2025-05-13	爱斯特（成都）生物制药股份有限公司	一种制备5-溴苯并[d][1,3]二氧-4-胺的方法
WO2025009910A1 (ko) *	2023-07-04	2025-01-09	부산대학교 산학협력단	퀴나졸린 유도체 화합물 및 이의 용도

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5411963A (en)	1988-01-29	1995-05-02	Dowelanco	Quinazoline derivatives
IL89029A (en)	1988-01-29	1993-01-31	Lilly Co Eli	Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
US5710158A (en)	1991-05-10	1998-01-20	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
SG64322A1 (en)	1991-05-10	1999-04-27	Rhone Poulenc Rorer Int	Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
US5721237A (en)	1991-05-10	1998-02-24	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
NZ243082A (en)	1991-06-28	1995-02-24	Ici Plc	4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
RU2043352C1 (ru) *	1991-07-01	1995-09-10	Пермский фармацевтический институт	2-пропил-3- (5-нитрофурфулиден)амино- 4(3н)-хиназолинон, проявляющий противостафилококковую и анальгетическую активность
PT100905A (pt)	1991-09-30	1994-02-28	Eisai Co Ltd	Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
AU661533B2 (en)	1992-01-20	1995-07-27	Astrazeneca Ab	Quinazoline derivatives
GB9323290D0 (en)	1992-12-10	1994-01-05	Zeneca Ltd	Quinazoline derivatives
RU2118322C1 (ru) *	1993-07-05	1998-08-27	Дюфар Интернэшнл Рисерч Б.В.	2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
WO1995023141A1 (en)	1994-02-23	1995-08-31	Pfizer Inc.	4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents
WO1995024190A2 (en) *	1994-03-07	1995-09-14	Sugen, Inc.	Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
GB9510757D0 (en)	1994-09-19	1995-07-19	Wellcome Found	Therapeuticaly active compounds
GB9419318D0 (en) *	1994-09-24	1994-11-09	Pfizer Ltd	Therapeutic agents
TW321649B (no)	1994-11-12	1997-12-01	Zeneca Ltd
GB2295387A (en)	1994-11-23	1996-05-29	Glaxo Inc	Quinazoline antagonists of alpha 1c adrenergic receptors
GB9424233D0 (en)	1994-11-30	1995-01-18	Zeneca Ltd	Quinazoline derivatives
EP2163546B1 (en)	1995-03-30	2016-06-01	Pfizer Products Inc.	Quinazoline derivatives
US6046206A (en)	1995-06-07	2000-04-04	Cell Pathways, Inc.	Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
GB9514265D0 (en)	1995-07-13	1995-09-13	Wellcome Found	Hetrocyclic compounds
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
US5760041A (en)	1996-02-05	1998-06-02	American Cyanamid Company	4-aminoquinazoline EGFR Inhibitors
AU719434B2 (en)	1996-02-13	2000-05-11	Astrazeneca Ab	Quinazoline derivatives as VEGF inhibitors
GB9603095D0 (en)	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline derivatives
GB9603097D0 (en)	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline compounds
GB9607729D0 (en)	1996-04-13	1996-06-19	Zeneca Ltd	Quinazoline derivatives
EP0912559B1 (en)	1996-07-13	2002-11-06	Glaxo Group Limited	Fused heterocyclic compounds as protein tyrosine kinase inhibitors
AUPO257096A0 (en) *	1996-09-25	1996-10-17	Bhp Steel (Jla) Pty Limited	Production of striped coatings on strip
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
EP0837063A1 (en)	1996-10-17	1998-04-22	Pfizer Inc.	4-Aminoquinazoline derivatives
AR012634A1 (es)	1997-05-02	2000-11-08	Sugen Inc	Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
TW436485B (en)	1997-08-01	2001-05-28	American Cyanamid Co	Substituted quinazoline derivatives
HUP0102793A3 (en)	1998-05-28	2002-07-29	Parker Hughes Inst St Paul	Quinazolines for treating brain tumor and medicaments containing them
EP1091739A1 (en)	1998-06-30	2001-04-18	Parker Hughes Institute	Method for inhibiting c-jun expression using jak-3 inhibitors
KR20010089171A (ko)	1998-08-21	2001-09-29	추후제출	퀴나졸린 유도체
HK1039126B (en)	1998-10-08	2005-09-30	阿斯特拉曾尼卡有限公司	Quinazoline derivatives
IL132366A0 (en) *	1998-10-15	2001-03-19	Cell Pathways Inc	Methods for identifying compounds for inhibition of neoplastic lesions and pharmaceutical compositions containing such compounds
MXPA01008182A (es) *	1999-02-10	2003-08-20	Astrazeneca Ab	Derivados de quinazolina como inhibidores de angiotensina.
KR20020068261A (ko)	1999-02-27	2002-08-27	베링거 잉겔하임 파르마 카게	티로신 키나제에 의해 매개되는 신호 변환에 대한 억제효과를 갖는 4-아미노-퀴나졸린 및 퀴놀린 유도체
US6080747A (en)	1999-03-05	2000-06-27	Hughes Institute	JAK-3 inhibitors for treating allergic disorders
DE19911509A1 (de)	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
GB9922173D0 (en)	1999-09-21	1999-11-17	Zeneca Ltd	Chemical compounds
SK3832002A3 (en)	1999-09-21	2002-11-06	Astrazeneca Ab	Quinazoline compounds and pharmaceutical compositions containing them
KR20020032612A (ko)	1999-09-21	2002-05-03	다비드 에 질레스	퀴나졸린 유도체 및 그의 의약으로서의 용도
DK1274692T3 (da)	2000-04-07	2006-10-30	Astrazeneca Ab	Quinazolinforbindelser
UA73993C2 (uk)	2000-06-06	2005-10-17	Астразенека Аб	Хіназолінові похідні для лікування пухлин та фармацевтична композиція
AU2001292138A1 (en)	2000-10-13	2002-04-22	Astrazeneca Ab	Quinazoline derivatives with anti-tumour activity
AU2001292137A1 (en)	2000-10-13	2002-04-22	Astrazeneca Ab	Quinazoline derivatives
US20040063733A1 (en)	2000-10-25	2004-04-01	Lambert Christine Marie Paul	Quinazoline derivatives
WO2002085895A1 (en)	2001-04-19	2002-10-31	Astrazeneca Ab	Quinazoline derivatives
ES2272737T3 (es)	2001-07-16	2007-05-01	Astrazeneca Ab	Derivados de quinolina y su uso como inhibidores de tirosina quinasas.

2001
- 2001-08-15 CA CA002419301A patent/CA2419301C/en not_active Expired - Fee Related
- 2001-08-15 AU AU2001278609A patent/AU2001278609B2/en not_active Ceased
- 2001-08-15 KR KR1020037002441A patent/KR100821446B1/ko not_active Expired - Fee Related
- 2001-08-15 AU AU7860901A patent/AU7860901A/xx active Pending
- 2001-08-15 MX MXPA03001332A patent/MXPA03001332A/es active IP Right Grant
- 2001-08-15 PL PL360591A patent/PL202812B1/pl not_active IP Right Cessation
- 2001-08-15 BR BR0113358-6A patent/BR0113358A/pt not_active Application Discontinuation
- 2001-08-15 KR KR1020087005460A patent/KR20080027400A/ko not_active Withdrawn
- 2001-08-15 CZ CZ2003486A patent/CZ2003486A3/cs unknown
- 2001-08-15 US US10/344,678 patent/US7115615B2/en not_active Expired - Fee Related
- 2001-08-15 RU RU2003107683/04A patent/RU2267489C2/ru not_active IP Right Cessation
- 2001-08-15 NZ NZ523702A patent/NZ523702A/en unknown
- 2001-08-15 WO PCT/GB2001/003649 patent/WO2002016352A1/en not_active Ceased
- 2001-08-15 SK SK214-2003A patent/SK2142003A3/sk not_active Application Discontinuation
- 2001-08-15 EE EEP200300071A patent/EE05387B1/xx not_active IP Right Cessation
- 2001-08-15 JP JP2002521453A patent/JP2004506732A/ja not_active Ceased
- 2001-08-15 CN CNB018177409A patent/CN100347169C/zh not_active Expired - Fee Related
- 2001-08-15 EP EP01956688A patent/EP1313727A1/en not_active Withdrawn
- 2001-08-15 IL IL15413101A patent/IL154131A0/xx unknown
- 2001-08-20 MY MYPI20013907A patent/MY129809A/en unknown
- 2001-08-21 AR ARP010103972A patent/AR033560A1/es not_active Application Discontinuation
- 2001-09-14 TW TW90122895A patent/TWI280960B/zh not_active IP Right Cessation
2003
- 2003-01-26 IL IL154131A patent/IL154131A/en not_active IP Right Cessation
- 2003-02-20 NO NO20030795A patent/NO326515B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ2003486A3 (cs)	2003-05-14
WO2002016352A1 (en)	2002-02-28
AR033560A1 (es)	2003-12-26
AU2001278609B2 (en)	2005-04-14
CN100347169C (zh)	2007-11-07
RU2267489C2 (ru)	2006-01-10
IL154131A (en)	2010-04-15
NO20030795L (no)	2003-04-04
MXPA03001332A (es)	2004-07-08
US7115615B2 (en)	2006-10-03
EE200300071A (et)	2004-12-15
CN1471527A (zh)	2004-01-28
CA2419301A1 (en)	2002-02-28
PL202812B1 (pl)	2009-07-31
KR20080027400A (ko)	2008-03-26
IL154131A0 (en)	2003-07-31
NZ523702A (en)	2004-08-27
EP1313727A1 (en)	2003-05-28
CA2419301C (en)	2009-12-08
US20040034046A1 (en)	2004-02-19
SK2142003A3 (en)	2003-07-01
EE05387B1 (et)	2011-02-15
BR0113358A (pt)	2003-07-01
JP2004506732A (ja)	2004-03-04
KR100821446B1 (ko)	2008-04-10
KR20030022416A (ko)	2003-03-15
MY129809A (en)	2007-05-31
AU7860901A (en)	2002-03-04
PL360591A1 (en)	2004-09-06
TWI280960B (en)	2007-05-11
NO326515B1 (no)	2008-12-22

Publication	Publication Date	Title
NO20030795L (no)	2003-04-04	Kinazolinderivater
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
DE10136334B8 (de)	2009-11-26	Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
ATA2932001A (de)	2004-11-15	Schneefräse
DE50100710D1 (de)	2003-11-06	Wischblatt
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
NO20030276D0 (no)	2003-01-20	Fremgangsmåte
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE10192638T1 (de)	2002-10-31	Bohrstangenladevorrichtung
NO20035573L (no)	2004-02-16	Kinazolinderivater
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
DE10196064T1 (de)	2003-03-13	Halbleiterfotodektionsgerät
DE50011511D1 (de)	2005-12-08	Blowby-Heizung
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es)	2003-04-16	Antitranspirantes
DE50007634D1 (de)	2004-10-07	Kardioplegieballonkatheter
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE10052925B4 (de)	2005-03-10	Schaukelbett
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung
DE10195909T1 (de)	2003-02-20	Viehfüttervorrichtung
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos
ATE284887T1 (de)	2005-01-15	Thienopyrrolidinone

Legal Events

Date	Code	Title	Description
2012-03-26	MM1K	Lapsed by not paying the annual fees